Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 09-1999 | 06-1999 | 03-1999 | 12-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,070 | -21,680 | -16,760 | -8,930 | -8,620 |
| Depreciation Amortization | 3,420 | 2,450 | 1,550 | 720 | 3,010 |
| Other Working Capital | 1,290 | -4,330 | 350 | -1,270 | -7,440 |
| Other Operating Activity | 4,530 | 2,770 | 1,750 | 1,060 | 2,850 |
| Operating Cash Flow | $-13,830 | $-20,790 | $-13,110 | $-8,420 | $-10,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,680 | -4,880 | -3,720 | -990 | -3,040 |
| Other Investing Activity | 23,140 | 29,300 | 17,270 | 10,820 | 5,480 |
| Investing Cash Flow | $17,460 | $24,420 | $13,550 | $9,830 | $2,440 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 300 | 140 | 370 | 610 | -1,400 |
| Financing Cash Flow | $300 | $140 | $370 | $610 | $-1,400 |
| Beginning Cash Position | 19,750 | 19,750 | 19,750 | 19,750 | 28,920 |
| End Cash Position | 23,690 | 23,520 | 20,560 | 21,770 | 19,750 |
| Net Cash Flow | $3,940 | $3,760 | $800 | $2,020 | $-9,160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,830 | -20,790 | -13,110 | -8,420 | -10,200 |
| Free Cash Flow | -13,830 | -20,790 | -13,110 | -8,420 | -10,200 |